A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1
Huang, David B, O’Riordan, William, Overcash, J Scott, Heller, Barry, Amin, Faisal, File, Thomas M, Wilcox, Mark H, Torres, Antoni, Dryden, Matthew, Holland, Thomas L, McLeroth, Patrick, Shukla, RajesLanguage:
english
Journal:
Clinical Infectious Diseases
DOI:
10.1093/cid/cix987
Date:
December, 2017
File:
PDF, 282 KB
english, 2017